Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Angela Lorts

Pediatric Cardiology Cincinnati, OH Medical Doctor

NPI 1861407348 CMS profile 644074

3333 Burnet Ave, Cincinnati, OH 45229

Open in the dashboard

General payments

$169,561

216 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Angela Lorts of Cincinnati, OH is reported in the CMS Open Payments database as having received $169,561 across 216 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,682 25
2024 General $18,500 30
2023 General $22,093 30
2022 General $14,336 24
2021 General $34,876 33
2020 General $24,481 31
2019 General $37,593 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angela Lorts
  • Pediatric Cardiology median
  • Middle half of Pediatric Cardiology
  • National median

In program year 2025, general payments to Angela Lorts were reported at $17,682. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.

Show as a table
Year Angela Lorts Pediatric Cardiology median Middle half National median
2019 $37,593 $124 $35–$516 $163
2020 $24,481 $70 $23–$326 $114
2021 $34,876 $112 $27–$445 $132
2022 $14,336 $129 $36–$680 $149
2023 $22,093 $149 $38–$826 $160
2024 $18,500 $131 $37–$652 $164
2025 $17,682 $146 $47–$670 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $149,486 184 payments
  2. Abiomed $16,403 18 payments
  3. Medtronic Vascular, Inc. $2,016 6 payments
  4. Medtronic, Inc. $1,500 5 payments
  5. Bayer HealthCare Pharmaceuticals Inc. $107 1 payment
  6. CVRx, Inc. $32 1 payment
  7. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $133,066 95 payments
  2. Travel and Lodging $14,416 42 payments
  3. Honoraria $13,000 2 payments
  4. Food and Beverage $5,016 75 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,063 2 payments
Products named General payments · program years 2019–2025
  1. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Heart failure $40,514 67 payments
  2. HeartMate 3 Left Ventricular Dev $36,583 44 payments
  3. HeartMate 3 Left Ventricular Assist Device $33,350 27 payments
  4. THORATEC HEARTMATE 3 LVAS IMPLANT KIT Structural Heart $17,399 22 payments
  5. Impella $16,136 16 payments
  6. CardioMEMS HF System $13,530 12 payments
  7. CARDIOMEMS $4,111 5 payments
  8. HeartMate $3,816 4 payments
  9. HeartWare HVAD $1,504 2 payments
  10. CentriMag $150 1 payment
  11. Other $182 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Critical Care (Intensivists): 406

Drug cost

$109

Median for Critical Care (Intensivists): $197,260

Branded share of claims

0%

Median for Critical Care (Intensivists): 69%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Warfarin Sodium Generic 14 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,531 Part D prescribers listed as Critical Care (Intensivists); they describe a distribution and say nothing about conduct.

Records

216 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Cardiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record